Pyrantel Pamoate/Praziquantel

Verify with FDA CVM →

961 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
961
Total Reports
68
Deaths Reported
710.0%
Death Rate

Active Ingredients

Pyrantel Pamoate/Praziquantel

Administration Routes

OralUnknownOphthalmic

Species Affected

Dog 932
Unknown 14
Human 8
Cat 7

Most Affected Breeds

Mixed (Dog) 164
Crossbred Canine/dog 115
Dog (unknown) 87
Chihuahua 69
American Pit Bull Terrier 63
Terrier - Yorkshire 39
Retriever - Labrador 37
Shih Tzu 29
Pit Bull 24
Unknown 22

Most Reported Reactions

Vomiting 488
Lethargy (see also Central nervous system depression in 'Neurological') 260
Diarrhoea 152
Not eating 73
Bloody diarrhoea 52
Death 51
Loose stool 45
Not drinking 45
Shaking 45
Anorexia 44
Overdose 42
Behavioural disorder NOS 33

Outcome Breakdown

Outcome Unknown
469 (49.5%)
Recovered/Normal
396 (41.8%)
Died
57 (6.0%)
Ongoing
15 (1.6%)
Euthanized
11 (1.2%)

Data Summary

Metric Value
Total adverse event reports 961
Reports involving death 68
Case-fatality rate (reported events) 710.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Pyrantel Pamoate/Praziquantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 961 adverse event reports referencing Pyrantel Pamoate/Praziquantel, including 68 reports in which the animal died — a 710.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Pyrantel Pamoate/Praziquantel. Reported administration routes include Oral, Unknown, Ophthalmic. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Pyrantel Pamoate/Praziquantel reports are Dog (932 reports), Unknown (14 reports), Human (8 reports), with Dog accounting for the largest share. Within those species, Mixed (Dog) (164), Crossbred Canine/dog (115), Dog (unknown) (87) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Pyrantel Pamoate/Praziquantel are Vomiting (488), Lethargy (see also Central nervous system depression in 'Neurological') (260), Diarrhoea (152), Not eating (73). Of the 948 reports with a coded outcome, Outcome Unknown is the leading category at 49.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Pyrantel Pamoate/Praziquantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial